Home › Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...
 

Keywords :   


Phico Therapeutics gets A 2.25M Translation Award to develop SASPject ...

2015-03-09 12:33:20| Biotech - Topix.net

Phico Therapeutics, a biotechnology company developing a novel platform technology for a new generation of antibiotics aimed at overcoming antibacterial resistance, has been awarded a 2.25M Translation Award by the Wellcome Trust to develop its SASPject PT4 antibiotic, aimed at Escherichia coli and Klebsiella pneumonia e . SASPject 's PT4 is targeted at E. coli and K. pneumoniae , including multi-drug resistant strains.

Tags: develop award translation therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.11Tropical Storm Rafael Graphics
05.11Tropical Storm Rafael Forecast Discussion Number 9
05.11Tropical Storm Rafael Wind Speed Probabilities Number 9
05.11Tropical Storm Rafael Public Advisory Number 9
05.11Summary for Tropical Storm Rafael (AT3/AL182024)
05.11Tropical Storm Rafael Forecast Advisory Number 9
05.11Kim Madigan to chair 2025 FTA Fall Technical Conference
05.11PM responds to Sir Alan Bates after repeated requests
More »